Jens Lindberg
Directeur Général chez MEDIVIR AB
Fortune : 32 862 $ au 31/05/2024
Postes actifs de Jens Lindberg
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MEDIVIR AB | Directeur Général | 24/01/2022 | - |
Historique de carrière de Jens Lindberg
Anciens postes connus de Jens Lindberg
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SEDANA MEDICAL AB | Directeur Général | 01/06/2021 | 01/09/2021 |
| Corporate Officer/Principal | 01/09/2021 | 01/01/2022 | |
AstraZeneca A/S /Denmark/
 AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Investor Relations Contact | 01/09/2013 | 01/10/2014 |
Statistiques
Internationale
| Suède | 3 |
| Danemark | 2 |
Opérationnelle
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 1 |
| Investor Relations Contact | 1 |
Sectorielle
| Health Technology | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SEDANA MEDICAL AB | Health Technology |
| MEDIVIR AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
AstraZeneca A/S /Denmark/
AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Bourse
- Insiders
- Jens Lindberg
- Expérience
